Patents by Inventor Steven L. Colletti

Steven L. Colletti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amide Derivatives as Inhibitors of Histone Deacetylase
    Publication number: 20080221157
    Abstract: The present invention relates to ketone derivatives that are inhibitors of histone deacetylase (HDAC). The compounds of the present invention are useful for treating cellular proliferative diseases, including cancer. Further, the compounds of the present invention are useful for treating neurodegenerative diseases, schizophrenia and stroke among other diseases.
    Type: Application
    Filed: July 11, 2005
    Publication date: September 11, 2008
    Applicants: ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGE, MERCK & CO. INC.
    Inventors: Prasun K. Chakravarty, Steven L. Colletti, Raffaele Ingenito, Philip Jones, Peter T. Meinke, Ester Muraglia, Alessia Petrocchi, Michael Rowley, Rita Scarpelli, Christian Steinkuhler
  • Selective non-steroidal glucocorticoid receptor modulators
    Patent number: 7411073
    Abstract: The present invention encompasses compounds of Formula (I) or pharmaceutically acceptable salts or hydrates thereof, which are useful as novel non-steroidal selective glucocorticoid receptor modulators for treating a variety of autoimmune and inflammatory diseases or conditions, and possess advantages over steroidal glucocorticoid ligands with respect to undesireable side-effects, efficacy, toxicity and/or metabolism. Pharmaceutical compositions and methods of use are also included.
    Type: Grant
    Filed: February 20, 2004
    Date of Patent: August 12, 2008
    Assignee: Merck & Co., Inc.
    Inventors: Amjad Ali, Richard Beresis, Steven L. Colletti, Donald W. Graham, James R. Tata, Christopher F. Thompson
  • (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds
    Patent number: 7196095
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof are useful in the treatment of cytokine mediated diseases such as arthritis and in the treatment and/or prevention of protozoal diseases such as coccidiosis
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: March 27, 2007
    Assignee: Merck & Co., Inc.
    Inventors: Tesfaye Biftu, Richard Beresis, Richard Berger, Steven L. Colletti, James B. Doherty, Dennis D. Feng, Gui-Bai Liang, Dennis M. Schmatz, Xiaoxia Qian, David A. Claremon, Nigel J. Liverton, Charles J. McIntyre, Ernest W. Kovacs
  • C1 to C4 side chain modified nodulisporic acid analogs
    Patent number: 6586452
    Abstract: The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents.
    Type: Grant
    Filed: July 9, 2001
    Date of Patent: July 1, 2003
    Assignee: Merck & Co., Inc.
    Inventors: Thomas Shih, Steven L. Colletti, Michael H. Fisher, Peter T. Meinke, Howard C. H. Kuo, Prasun K. Chakravarty, Matthew J. Wyvratt, Sriram Tyagarajan, Richard Berger
  • Apicidin-derived cyclic tetrapeptides
    Publication number: 20030078369
    Abstract: Cyclic tetrapeptide compounds derived from apicidin therapeutically inhibit histone deacetylase activity, are represented by Formula I: 1
    Type: Application
    Filed: January 31, 2002
    Publication date: April 24, 2003
    Inventors: Peter T. Meinke, Dennis Schmatz, Robert W. Myers, Sandra J. Rattray, Steven L. Colletti, Matthew J. Wyvratt, Michael H. Fisher, Anne M. Gurnett
  • Nonacyclic nodulisporic acid derivatives
    Patent number: 6399786
    Abstract: The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents.
    Type: Grant
    Filed: July 9, 2001
    Date of Patent: June 4, 2002
    Assignee: Merck & Co., Inc.
    Inventors: Steven L. Colletti, Michael H. Fisher, Peter T. Meinke, Matthew J. Wyvratt
  • C4 side-chain modified nodulisporic acid analogs
    Publication number: 20020045653
    Abstract: The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents.
    Type: Application
    Filed: July 9, 2001
    Publication date: April 18, 2002
    Inventors: Thomas Shih, Steven L. Colletti, Michael H. Fisher, Peter T. Meinke, Dong Ok, Prasun K. Chakravarty, Matthew J. Wyvratt
  • Nonacyclic nodulisporic acid derivatives
    Publication number: 20020045598
    Abstract: The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents.
    Type: Application
    Filed: July 9, 2001
    Publication date: April 18, 2002
    Inventors: Steven L. Colletti, Michael H. Fisher, Peter T. Meinke, Matthew J. Wyvratt